Related content

Increased liability of tramadol–warfarin interaction in individuals with mutations in the cytochrome P ₄₅₀ 2D6 gene

By Hedenmalm Karin   Lindh Jonatan   Säwe Juliette   Rane Anders  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 369-372

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the novel anxiolytic drug deramciclane on cytochrome P ₄₅₀ 2D6 activity as measured by desipramine pharmacokinetics

By Laine Kari   Bruyn Steven   Björklund Harry   Rouru Juha   Hänninen Jutta   Scheinin Harry   Anttila Markku  

European Journal of Clinical Pharmacology, Vol. 59, Iss. 12, 2004-02 ,pp. : 893-898

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphism of cytochrome P₄₅₀ 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

By Lee Ai-Young   Kim Min-Jung   Chey Won-Young   Choi Jun   Kim Byung-Gun  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 155-159

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P₄₅₀ 2C9 phenotyping using low-dose tolbutamide

By Jetter Alexander   Kinzig-Schippers Martina   Skott Andreas   Lazar Andreas   Tomalik-Scharte Dorota   Kirchheiner Julia   Walchner-Bonjean Monika   Hering Ursula   Jakob Verena   Rodamer Michael   Jabrane Wafaâ   Kasel Dirk   Brockmöller Jürgen   Fuhr Uwe   Sörgel Fritz  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 2C19 (CYP2C19) genotype appears to affect the efficacy of omeprazole

By  

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite